1-3 of 3
Chenqiang Jia
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 6976: Identification of novel KAT6A/B inhibitors with enhanced antitumor activity and reduced hematologic toxicity

Free
Rui Liu, Yushi Chi, Xiayan Zhang, Xuemei Tian, Chenqiang Jia, Zhiliang Lv, Huixin Yan, Qian Zou, Liping Han, Wan-Jen Yang, Jijun Yuan, Xiaoling Yuan, Zhiyu Ma, Yi Zhang, Yongqiang Shan, Chen Hu
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_1): 6976.
https://doi.org/10.1158/1538-7445.AM2025-6976
Published: 21 April 2025
View articletitled, Abstract 6976: Identification of novel KAT6A/B inhibitors with enhanced antitumor activity and reduced hematologic toxicity
Journal Articles

Abstract 5730: Discovery of a novel antibody-drug conjugate linker-payload with a distinct killing mechanism via prolonged unfolded protein response activation

Free
Rui Liu, Yushi Chi, Yongqiang Shan, Chenqiang Jia, Yingying Zhang, Xiayan Zhang, Wentao Zhang, Xuemei Tian, Yifan Zhang, Fan Yang, Dongmei Han, Simon Hsu, Jiamin Su, Jijun Yuan, Wan-Jen Yang, Xiaoling Yuan, Zhiyu Ma, Chen Hu
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_1): 5730.
https://doi.org/10.1158/1538-7445.AM2025-5730
Published: 21 April 2025
View articletitled, Abstract 5730: Discovery of a novel antibody-drug conjugate linker-payload with a distinct killing mechanism via prolonged unfolded protein response activation
Journal Articles

Dual Inhibition of CDK12/CDK13 Targets Both Tumor and Immune Cells in Ovarian Cancer

Available to Purchase
Lin Cheng, Shichao Zhou, Shaoqing Zhou, Kaixuan Shi, Yan Cheng, Mei-Chun Cai, Kaiyan Ye, Lifeng Lin, Zhenfeng Zhang, Chenqiang Jia, Huaijiang Xiang, Jingyu Zang, Meiying Zhang, Xia Yin, Ying Li, Wen Di, Guanglei Zhuang, Li Tan
Journal: Cancer Research
Cancer Res (2022) 82 (19): 3588–3602.
https://doi.org/10.1158/0008-5472.CAN-22-0222
Published: 04 October 2022
View articletitled, Dual Inhibition of CDK12/CDK13 Targets Both Tumor and Immune Cells in Ovarian Cancer
Open the PDF for Dual Inhibition of CDK12/CDK13 Targets Both Tumor and Immune Cells in Ovarian Cancer in another window
Includes: Supplementary data